Litcius/Paper detail

Efficacy and safety of fexinidazole for treatment of chronic indeterminate Chagas disease (FEXI-12): a multicentre, randomised, double-blind, phase 2 trial

María‐Jesús Pinazo, Colin Forsyth, Irene Losada, Elena Trigo Esteban, Magdalena García-Rodríguez, Maria Luz Villegas, Israel Molina, Clara Crespillo‐Andújar, Montserrat Gállego, Cristina Ballart, Juan Carlos Ramı́rez, Tilman Aden, Achim Hoerauf, Kenneth Pfarr, Michel Vaillant, Tayná Marques, Jayme Fernandes, Bethania Blum, Isabela Ribeiro, Sergio Sosa‐Estáni, Fabiana Barreira, Joaquím Gascón

2024The Lancet Infectious Diseases57 citationsDOIOpen Access PDF

Topics & Concepts

BenznidazoleMedicineNifurtimoxChagas diseasePlaceboAdverse effectInternal medicineClinical trialClinical endpointRashSurgeryTrypanosoma cruziImmunologyPathologyAlternative medicineParasite hostingComputer scienceWorld Wide WebTrypanosoma species research and implicationsResearch on Leishmaniasis StudiesParasitic Diseases Research and Treatment